Page last updated: 2024-09-03

ym 264 and web 2086

ym 264 has been researched along with web 2086 in 2 studies

Compound Research Comparison

Studies (ym 264)	Trials (ym 264)	Recent Studies (post-2010) (ym 264)	Studies (web 2086)	Trials (web 2086)	Recent Studies (post-2010) (web 2086)
9	0	0	600	8	31

Protein Interaction Comparison

Protein	Taxonomy	ym 264 (IC50)	web 2086 (IC50)
Platelet-activating factor receptor	Cavia porcellus (domestic guinea pig)		0.1093
Platelet-activating factor receptor	Homo sapiens (human)		0.1735

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T	1
Bird, IN; Daniels, RH; Elmore, MA; Finnen, MJ; Hill, ME	1

Other Studies

2 other study(ies) available for ym 264 and web 2086

Article	Year
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat. Biochemical and biophysical research communications, 1991, Apr-30, Volume: 176, Issue:2 Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles	1991
Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers. Journal of immunology (Baltimore, Md. : 1950), 1994, Oct-15, Volume: 153, Issue:8 Topics: Arachidonic Acid; Azepines; Cell Adhesion; Cell Movement; Cell Polarity; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-1; Neutrophil Activation; Neutrophils; Piperazines; Platelet Activating Factor; Superoxides; Thiazoles; Thiazolidines; Triazoles	1994

Article

Year

Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.

Biochemical and biophysical research communications, 1991, Apr-30, Volume: 176, Issue:2

Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles

1991

Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.

Journal of immunology (Baltimore, Md. : 1950), 1994, Oct-15, Volume: 153, Issue:8

Topics: Arachidonic Acid; Azepines; Cell Adhesion; Cell Movement; Cell Polarity; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-1; Neutrophil Activation; Neutrophils; Piperazines; Platelet Activating Factor; Superoxides; Thiazoles; Thiazolidines; Triazoles

1994

chemdatabank.com